//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Am doing an informal poll- will bluesky or X give most reposts for our last paper? @benoyshah.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @jgrapsa.bsky.social @anastasiasmihaili.bsky.social @annakatebarton.bsky.social @tharusha.bsky.social academic.oup.com/eurjpc/advan...
Mar 7, 2025
AbstractAims. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are recognized for their cardiovascular benefits. This systematic review and meta-analysis
academic.oup.com
Impact of sodium–glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis
Vass Vassiliou
Mar 6, 2025
Our latest paper on EJPC @escardio.bsky.social on use of SGLT2i in cancer patients… Reduces heart failure hospitalisation by 50%! And mortality! Breaat ca pts benefit most Read it at: academic.oup.com/eurjpc/advan... @drmarthagulati.bsky.social @purviparwani.bsky.social @mmamas1973.bsky.social
Vass Vassiliou